The longevity boom is getting ahead of the science
World1 source1 country🔦 Under-reported26m ago
Billions of dollars are currently being invested into anti-ageing biotechnology, driving a significant longevity boom. However, this rapid influx of capital and interest is outpacing the underlying scientific understanding.
Manipulating the human ageing process carries inherent risks that researchers and experts are only beginning to comprehend and evaluate.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Al JazeeraFocuses on the financial surge into anti-ageing biotech and associated biological risks.
Newz